Verona Pharma plc - American Depositary Shares (VRNA)
84.34
-1.20 (-1.40%)
NASDAQ · Last Trade: Jun 8th, 4:10 AM EDT
Detailed Quote
Previous Close
85.54
Open
85.79
Bid
83.62
Ask
84.34
Day's Range
82.18 - 86.26
52 Week Range
11.79 - 86.59
Volume
1,740,317
Market Cap
40.51B
PE Ratio (TTM)
-337.36
EPS (TTM)
-0.3
Dividend & Yield
N/A (N/A)
1 Month Average Volume
1,433,199
Chart
About Verona Pharma plc - American Depositary Shares (VRNA)
Verona Pharma is a biopharmaceutical company focused on developing innovative therapies for respiratory diseases. The company concentrates on the discovery and development of impactful drugs that address significant unmet medical needs in conditions such as chronic obstructive pulmonary disease (COPD) and asthma. Their research and pipeline involve novel mechanisms of action, aiming to improve patient outcomes and quality of life through enhanced treatment options. Verona Pharma utilizes its expertise in drug development to advance potential therapies from preclinical stages through clinical trials. Read More
The FDA has approved Verona Pharma's Ohtuvayre (ensifentrine) as maintenance treatment of chronic obstructive pulmonary disease in adults. The drug could generate $3.6 billion in peak sales.
